Zoetis is the world's largest animal health company. Zoetis may very well be a recession-proof company. Despite the pandemic, Zoetis has prospered. The majority of the company's revenues come from the companion animal market. The stay-at-home phenomena have increased pet ownership and made pet owners more aware of their pet's physical situation. Couple that with Zoetis' animal drug development, the addition of point-of-care services and you have a company making the most of a bad situation. That is what I am talking about today on the Daily Stock Analysis.

Listen, learn, & subscribe. If you'd like to view this episode or previous episodes, visit https://youtube.com/c/richardsfinancialplanning #investing #economy #drugspharmaceuticals

Additionally, if you are in Texas and you're frustrated with your personal financial growth, I have a new program for that called the Prosperous Planning Process. Learn more about turning a lack of financial control into abundance at https://richardsfinancialplanning.com/

One last point from our sponsor, Advice4LifeInsurance.com.  If you need life insurance, you can find the best life insurance at the lowest price in less than five minutes.  Visit their website at https://www.advice4lifeinsurance.com

Not an official Zoetis video. For educational purposes only. Not an offer to buy or sell any stock or an offer of advice.

There are limits to the information provided. At the end of the video, please read the disclosure. Or at the end of the podcast, please listen to the disclosure for Richards Financial Planning, LLC.

References from today's show:

Zoetis third quarter 2020 financial results https://s1.q4cdn.com/446597350/files/doc_financials/2020/q3/3Q'20-Earnings-Presentation-11.5.20-Final.pdf

Zoetis Inc. Form 10Q https://s1.q4cdn.com/446597350/files/doc_financials/2020/q3/4dbe106d-94fc-4899-bb4f-a4827978c1ec.pdf

Jim Cramer has a great video interview with Zoetis CEO Kristin Peck https://www.cnbc.com/video/2021/01/13/families-are-adopting-spending-more-on-pets-amid-pandemic-zoetis-ceo.html

Even though it's not a huge dividend, Zoetis has increased its dividend each year since its inception in 2013. December 9, 2020, Zoetis increased its dividend by 25%. (FYI, it is essential to remember that the past performance, including its dividends, is not a guarantee of future results.) https://investor.zoetis.com/news/news-details/2020/Zoetis-Declares-First-Quarter-2021-Dividend-Board-Approves-25-Payment-Increase/default.aspx#:~:text=The%20Board%20of%20Directors%20of%20Zoetis%20Inc%20.,%E2%80%9CZoetis%20continues%20to%20demonstrate%20its%20resiliency%20and

In 2018 Zoetis merged with Abaxis, a company that develops, manufactures, and markets veterinary diagnostic instruments. https://www.abaxis.com/news/press-release/zoetis-to-acquire-abaxis-leading-global-provider-of-veterinary-point-of-care

In 2019, Zoetis took further steps to diversify its revenue stream by acquiring ZNLabs a nationwide veterinary reference laboratory

https://news.zoetis.com/press-releases/press-release-details/2019/Zoetis-Acquires-ZNLabs-a-Nationwide-Veterinary-Reference-Laboratory-to-Further-Strengthen-its-Comprehensive-Diagnostics-Portfolio/default.aspx